| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alfredo Spagna, Yi Dong, Melissa-Ann Mackie, Ming Li, Philip D Harvey, Yanghua Tian, Kai Wang, Jin Fa. Clozapine improves the orienting of attention in schizophrenia. Schizophrenia research. vol 168. issue 1-2. 2016-07-06. PMID:26298539. |
the enhancement of the orienting function by clozapine may increase the ability of patients with schizophrenia to orient towards objects and thoughts of interest. |
2016-07-06 |
2023-08-13 |
Not clear |
| Sally-Anne Knowles, Sara S Mcmillan, Amanda J Wheele. Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom? Pharmacy practice. vol 14. issue 2. 2016-07-06. PMID:27382426. |
clozapine is an antipsychotic medication used in treatment resistant schizophrenia. |
2016-07-06 |
2023-08-13 |
Not clear |
| Selcuk Yaylaci, Emine Ulku Yilmaz, Ertugrul Guclu, Neslihan Akkisi Kumsar, Ali Tamer, Oguz Karaba. Clozapine-Induced Febrile Neutropenia and Cellulitis. Turkish journal of emergency medicine. vol 14. issue 1. 2016-06-22. PMID:27331165. |
clozapine is one of the atypical antipsychotics and is frequently prescribed to patients with treatment-resistant schizophrenia. |
2016-06-22 |
2023-08-13 |
Not clear |
| T Scott Stroup, Tobias Gerhard, Stephen Crystal, Cecilia Huang, Mark Olfso. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia. The American journal of psychiatry. vol 173. issue 2. 2016-06-20. PMID:26541815. |
comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia. |
2016-06-20 |
2023-08-13 |
Not clear |
| T Scott Stroup, Tobias Gerhard, Stephen Crystal, Cecilia Huang, Mark Olfso. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia. The American journal of psychiatry. vol 173. issue 2. 2016-06-20. PMID:26541815. |
the authors compared the effectiveness of initiating treatment with either clozapine or a standard antipsychotic among adults with evidence of treatment-resistant schizophrenia in routine clinical practice. |
2016-06-20 |
2023-08-13 |
Not clear |
| Leonel E Rojo, Pablo A Gaspar, H Silva, L Risco, Pamela Arena, Karen Cubillos-Robles, Belen Jar. Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacological research. vol 101. 2016-06-10. PMID:26218604. |
second generation antipsychotics (sgas), such as clozapine, olanzapine, risperidone and quetiapine, are among the most effective therapies to stabilize symptoms schizophrenia (sz) spectrum disorders. |
2016-06-10 |
2023-08-13 |
Not clear |
| C-L Hou, M-Y Cai, X-R Ma, Y Zang, F-J Jia, Y-Q Lin, H F K Chiu, G S Ungvari, C H Ng, B-L Zhong, X-L Cao, Y Li, N Shinfuku, Y-T Xian. Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care. Pharmacopsychiatry. vol 48. issue 6. 2016-06-03. PMID:26244858. |
clozapine prescription and quality of life in chinese patients with schizophrenia treated in primary care. |
2016-06-03 |
2023-08-13 |
Not clear |
| C-L Hou, M-Y Cai, X-R Ma, Y Zang, F-J Jia, Y-Q Lin, H F K Chiu, G S Ungvari, C H Ng, B-L Zhong, X-L Cao, Y Li, N Shinfuku, Y-T Xian. Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care. Pharmacopsychiatry. vol 48. issue 6. 2016-06-03. PMID:26244858. |
clozapine is frequently used to treat schizophrenia in china. |
2016-06-03 |
2023-08-13 |
Not clear |
| C-L Hou, M-Y Cai, X-R Ma, Y Zang, F-J Jia, Y-Q Lin, H F K Chiu, G S Ungvari, C H Ng, B-L Zhong, X-L Cao, Y Li, N Shinfuku, Y-T Xian. Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care. Pharmacopsychiatry. vol 48. issue 6. 2016-06-03. PMID:26244858. |
this study described the frequency, demographic and clinical characteristics of clozapine treatment and its impact on insight and quality of life (qol) of patients with schizophrenia treated in primary care in china. |
2016-06-03 |
2023-08-13 |
Not clear |
| Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, Valerie Powell, Amaal Bhaloo, Robert Bies, Gary Remingto. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study. Journal of clinical psychopharmacology. vol 35. issue 5. 2016-06-01. PMID:26267420. |
clozapine is the antipsychotic of choice for treatment-resistant schizophrenia and is linked to a need for mandatory hematological monitoring. |
2016-06-01 |
2023-08-13 |
Not clear |
| Venuja Sriretnakumar, Eric Huang, Daniel J Mülle. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update. Expert opinion on drug metabolism & toxicology. vol 11. issue 11. 2016-06-01. PMID:26364648. |
pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update. |
2016-06-01 |
2023-08-13 |
Not clear |
| Venuja Sriretnakumar, Eric Huang, Daniel J Mülle. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update. Expert opinion on drug metabolism & toxicology. vol 11. issue 11. 2016-06-01. PMID:26364648. |
clozapine (clz) is the most effective treatment for treatment-resistant schizophrenia (scz) patients, with potential added benefits of reduction in suicide risk and aggression. |
2016-06-01 |
2023-08-13 |
Not clear |
| Zhengrong Liu, Wei Zheng, Shuai Gao, Zhisong Qin, Guannan Li, Yuping Nin. Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis. Shanghai archives of psychiatry. vol 27. issue 6. 2016-05-20. PMID:27199524. |
long-term use of clozapine for individuals with schizophrenia carries a high risk for developing metabolic abnormalities, especially clozapine-induced weight gain. |
2016-05-20 |
2023-08-13 |
Not clear |
| Mohamed Ahmed, Dara M Cannon, Cathy Scanlon, Laurena Holleran, Heike Schmidt, John McFarland, Camilla Langan, Peter McCarthy, Gareth J Barker, Brian Hallahan, Colm McDonal. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 10. 2016-05-09. PMID:25829144. |
progressive brain atrophy and cortical thinning in schizophrenia after commencing clozapine treatment. |
2016-05-09 |
2023-08-13 |
Not clear |
| Mohamed Ahmed, Dara M Cannon, Cathy Scanlon, Laurena Holleran, Heike Schmidt, John McFarland, Camilla Langan, Peter McCarthy, Gareth J Barker, Brian Hallahan, Colm McDonal. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 10. 2016-05-09. PMID:25829144. |
despite evidence that clozapine may be neuroprotective, there are few longitudinal magnetic resonance imaging (mri) studies that have specifically explored an association between commencement of clozapine treatment for schizophrenia and changes in regional brain volume or cortical thickness. |
2016-05-09 |
2023-08-13 |
Not clear |
| Mohamed Ahmed, Dara M Cannon, Cathy Scanlon, Laurena Holleran, Heike Schmidt, John McFarland, Camilla Langan, Peter McCarthy, Gareth J Barker, Brian Hallahan, Colm McDonal. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 10. 2016-05-09. PMID:25829144. |
a total of 33 patients with treatment-resistant schizophrenia and 31 healthy controls matched for age and gender underwent structural mri brain scans at baseline and 6-9 months after commencing clozapine. |
2016-05-09 |
2023-08-13 |
Not clear |
| Mohamed Ahmed, Dara M Cannon, Cathy Scanlon, Laurena Holleran, Heike Schmidt, John McFarland, Camilla Langan, Peter McCarthy, Gareth J Barker, Brian Hallahan, Colm McDonal. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 10. 2016-05-09. PMID:25829144. |
these findings demonstrate on-going reductions in brain volume and progressive cortical thinning in patients with schizophrenia who are switched to clozapine treatment. |
2016-05-09 |
2023-08-13 |
Not clear |
| Alp Üçok, Uğur Çikrikçili, Sercan Karabulut, Ada Salaj, Meliha Öztürk, Öznur Tabak, Rümeysa Dura. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia. International clinical psychopharmacology. vol 30. issue 5. 2016-05-02. PMID:26163875. |
delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia. |
2016-05-02 |
2023-08-13 |
Not clear |
| Alp Üçok, Uğur Çikrikçili, Sercan Karabulut, Ada Salaj, Meliha Öztürk, Öznur Tabak, Rümeysa Dura. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia. International clinical psychopharmacology. vol 30. issue 5. 2016-05-02. PMID:26163875. |
the aim of this retrospective chart-review study was to investigate the relationship between delayed commencement of clozapine and the level of response in treatment-resistant schizophrenia (trs). |
2016-05-02 |
2023-08-13 |
Not clear |
| Alp Üçok, Uğur Çikrikçili, Sercan Karabulut, Ada Salaj, Meliha Öztürk, Öznur Tabak, Rümeysa Dura. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia. International clinical psychopharmacology. vol 30. issue 5. 2016-05-02. PMID:26163875. |
we included 162 patients with schizophrenia who used clozapine. |
2016-05-02 |
2023-08-13 |
Not clear |